CAREDX ANNOUNCES NEW KOAR DATA LINKING ELEVATED ALLOSURE® KIDNEY TO NEARLY 3-FOLD HIGHER RISK OF ADVERSE GRAFT OUTCOMES IN PATIENTS WITH BORDERLINE REJECTION OR TCMR AT ASN KIDNEY WEEK 2026

Reuters · 2d ago

Please log in to view news